Elanco Animal Health (ELAN) Share-based Compensation (2017 - 2026)

Elanco Animal Health has reported Share-based Compensation for 10 years, with the latest figure at $21.0 million in Q1 2026.

• Quarterly Share-based Compensation rose 61.54% year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.0 million (up 33.33% YoY) and the FY2025 annual result came in at $68.0 million, up 23.64% from the prior year.
• Share-based Compensation improved to $21.0 million in Q1 2026 per ELAN's latest filing, from $16.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $22.0 million in Q2 2025 and troughed at $9.0 million in Q2 2023.
• A 5-year average of $14.6 million and a median of $15.0 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2023 and 2026: Share-based Compensation sank 47.06% in 2023, then jumped 61.54% in 2026.
• Over 5 years, Share-based Compensation stood at $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then advanced by 6.67% to $16.0 million in 2025, then jumped by 31.25% to $21.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $21.0 million, $16.0 million, and $17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.